NYLI WMC Value Fund C (MMPCX)
21.77
-0.03
(-0.14%)
USD |
Oct 07 2025
Key Stats
Customize
Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
---|---|---|---|
2.02% | 963.12M | 2.18% | 36.00% |
1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
-118.21M | 7.74% | Upgrade | Upgrade |
Basic Info
Investment Strategy | |
The Fund seeks long-term appreciation of capital. The Fund also seeks to earn income as a secondary objective. The Fund normally invests at least 65% of its total assets in equity-type securities. |
General | |
Security Type | Mutual Fund |
Broad Asset Class | US Equity |
Broad Category | Equity |
Global Peer Group | Equity US |
Peer Group | Multi-Cap Value Funds |
Global Macro | Equity North America |
US Macro | Multi-Cap Funds |
YCharts Categorization | -- |
YCharts Benchmark | -- |
Prospectus Objective | Growth & Income Funds |
Fund Owner Firm Name | New York Life Investments |
Broad Asset Class Benchmark Index | |
^SPXTR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
65
-852.19M
Peer Group Low
1.202B
Peer Group High
1 Year
% Rank:
68
-118.21M
-6.075B
Peer Group Low
7.105B
Peer Group High
3 Months
% Rank:
75
-2.597B
Peer Group Low
1.461B
Peer Group High
3 Years
% Rank:
68
-10.39B
Peer Group Low
8.293B
Peer Group High
6 Months
% Rank:
72
-5.602B
Peer Group Low
2.001B
Peer Group High
5 Years
% Rank:
6
-12.93B
Peer Group Low
39.46B
Peer Group High
YTD
% Rank:
72
-6.336B
Peer Group Low
3.930B
Peer Group High
10 Years
% Rank:
43
-27.15B
Peer Group Low
69.74B
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of October 08, 2025.
Asset Allocation
As of August 31, 2025.
Type | % Net |
---|---|
Cash | -0.23% |
Stock | 99.01% |
Bond | 0.00% |
Convertible | 0.00% |
Preferred | 0.00% |
Other | 1.22% |
Top 10 Holdings
Name | % Weight | Price | % Change |
---|---|---|---|
Alphabet, Inc. | 4.06% | 245.48 | -0.67% |
JPMorgan Chase & Co. | 3.94% | 304.06 | -1.18% |
Johnson & Johnson | 2.72% | 189.74 | 0.45% |
Merck & Co., Inc. | 2.33% | 86.43 | -1.35% |
UnitedHealth Group, Inc. | 2.31% | 370.20 | 1.80% |
Cisco Systems, Inc. | 2.11% | 70.33 | 1.95% |
L3Harris Technologies, Inc. | 1.96% | 306.74 | 1.76% |
American International Group, Inc. | 1.82% | 83.99 | -0.07% |
Pfizer Inc. | 1.81% | 25.68 | -2.25% |
Archer-Daniels-Midland Co. | 1.80% | 62.21 | -1.08% |
Fees & Availability
Fees | |
Actual 12B-1 Fee | 1.00% |
Actual Management Fee | 0.66% |
Administration Fee | -- |
Maximum Front Load | -- |
Maximum Deferred Load | 1.00% |
Maximum Redemption Fee | -- |
General Availability | |
Available for Insurance Product | -- |
Available for RRSP | -- |
Purchase Details | |
Open to New Investors |
|
Minimum Initial Investment | 1000.00 None |
Minimum Subsequent Investment | 50.00 None |
Basic Info
Investment Strategy | |
The Fund seeks long-term appreciation of capital. The Fund also seeks to earn income as a secondary objective. The Fund normally invests at least 65% of its total assets in equity-type securities. |
General | |
Security Type | Mutual Fund |
Broad Asset Class | US Equity |
Broad Category | Equity |
Global Peer Group | Equity US |
Peer Group | Multi-Cap Value Funds |
Global Macro | Equity North America |
US Macro | Multi-Cap Funds |
YCharts Categorization | -- |
YCharts Benchmark | -- |
Prospectus Objective | Growth & Income Funds |
Fund Owner Firm Name | New York Life Investments |
Broad Asset Class Benchmark Index | |
^SPXTR | 100.0% |
Fundamentals
General | |
Distribution Yield | -- |
Dividend Yield TTM (10-6-25) | 1.29% |
30-Day SEC Yield (6-30-21) | -0.21% |
7-Day SEC Yield | -- |
Number of Holdings | 69 |
Stock | |
Weighted Average PE Ratio | 23.78 |
Weighted Average Price to Sales Ratio | 3.760 |
Weighted Average Price to Book Ratio | 4.948 |
Weighted Median ROE | 25.85% |
Weighted Median ROA | 6.80% |
ROI (TTM) | 12.05% |
Return on Investment (TTM) | 12.05% |
Earning Yield | 0.0508 |
LT Debt / Shareholders Equity | 0.9910 |
Number of Equity Holdings | 65 |
As of August 31, 2025
Growth Metrics
EPS Growth (1Y) | 7.39% |
EPS Growth (3Y) | 4.50% |
EPS Growth (5Y) | 9.31% |
Sales Growth (1Y) | 5.62% |
Sales Growth (3Y) | 5.82% |
Sales Growth (5Y) | 7.64% |
Sales per Share Growth (1Y) | 6.84% |
Sales per Share Growth (3Y) | 7.19% |
Operating Cash Flow - Growth Rate (3Y) | 0.14% |
As of August 31, 2025
Fund Details
Top Portfolio Holders
Name | % Weight |
---|---|
Portfolio A | 5.00% |
Portfolio B | 3.50% |
Portfolio C | 2.25% |
Excel Add-In Codes
Name: =YCI("M:MMPCX", "name") |
Broad Asset Class: =YCI("M:MMPCX", "broad_asset_class") |
Broad Category: =YCI("M:MMPCX", "broad_category_group") |
Prospectus Objective: =YCI("M:MMPCX", "prospectus_objective") |
To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |